Dubai PR Network, Online Press Release from Dubai and Middle East
 
Health & Fitness(Healthcare & Medicine)
Filter PR by
  
Medcare Aids Two Infants With Spinal Muscular Atrophy With Revolutionary Gene Therapy Worth USD 2.1 Million
 
Medcare Aids Two Infants With Spinal Muscular Atrophy With Revolutionary Gene Therapy Worth USD 2.1 Million

United Arab Emirates -  November 15, 2020:   The premium medical provider has offered the gene therapy as part of a global programme (Managed Access Programme) that has given access to the world’s most ground-breaking treatment to 100 Spinal Muscular Atrophy (SMA) patients in the world in 2020

Medcare Hospitals has become the first healthcare provider in the Middle East to offer the complimentary gene therapy to two infant patients suffering from Spinal Muscular Atrophy (SMA) type 1 as part of the Managed Access Programme (MAP) by Novartis. 

Novartis, a pharmaceutical company that develops this gene therapy for SMA, started this programme in 2020 to offer gene replacement therapy for free to 100 random patients in the world diagnosed with SMA. An infant is selected every 15 days as the part of this programme, and the first two in the Middle East have been chosen from Medcare Women & Children Hospital (MWCH).

Dr Shamsa Abdulla bin Hammad, Chief Operating Officer, Medcare Women and Children Hospital said: “We, at Medcare Women and Children Hospital, are proud to be the first hospital in UAE to start the treatment of Gene therapy for Spinal Muscular Atrophy! Under the #AveXisMAP program in the Middle East! This treatment is giving the gift of life which is one of the most fulfilling feeling and this is the reason we do what we do. Spreading smiles and health to all our patients has always been our priority”

Spinal Muscular Atrophy (SMA) is a genetic condition in which an essential protein called SMN is not produced as a gene responsible for its production called SMN1 is deleted or mutated, making the muscles weaker. The condition worsens over time, and can be fatal. A severe case (type 1) can mean that the child may not survive beyond couple of years. However, with the gene therapy, the patient can lead a normal, or close to normal life. 

Dr Vivek Mundada, Paediatric Neurologist at Medcare Women & Children Hospital, said: “Gene replacement therapy means replacing with a fully functional copy of the missing SMN1 gene, which is the root cause of the disease. The gene then enters targeted body cells and starts producing the missing SMN protein. 

“Children with SMA Type 1, who usually never achieve the developmental milestone of sitting and have received this gene replacement therapy, have learned to sit and have survived with good quality of life. Some have even achieved the milestone of walking. This therapy changes the natural course of the disease as their muscle power increases significantly and hence is the life-saving drug for this condition,” Dr Mundada said. 

Both the children receiving gene therapy suffer from SMA type 1, and will be the first in the Middle East to receive gene therapy under the MAP program. For one of them, the rapid genetic testing was performed using a clinically validated assay at Al Jalila Children’s Genomic Center, Dubai. The test result was ready within 48 hours, a rapid turnaround that would have taken 2-4 weeks if the test was sent abroad. This insured timely confirmation of the clinical diagnosis and suitability of the patient for the gene replacement therapy. MWCH is one of the few hospitals in the UAE that can accommodate this treatment programme. Dr Mundada also brings over ten years of expertise in this field leading a highly specialised clinical and research unit in London, aimed at helping children with neuromuscular problems.
 
“The infants had pre-therapy clinical assessments and necessary blood tests required for the therapy. The drug is specifically made for these children according to their weight. The children will be admitted to the intensive care unit, and all the staff, including nurses, pharmacists, and medical crew involved in the care of these children have received specialised training for storing, handling, and preparing the drug for infusion in the hospital setting,” Dr Mundada explained. 

The children will be monitored for at least 24 hours after the infusion. After the discharge, periodic assessments will be done by Dr Mundada and the paediatric physiotherapist at Medcare Women & Children Hospital to monitor their progress and other parameters like side effects. 

Parents have been educated on the condition SMA, including various monitoring required for the children. Apart from Dr Mundada, they have been seen by paediatric respiratory and gastrointestinal specialists. The children are receiving regular physiotherapy, with regular updates on the progress of this therapy being shared with the parents.


Posted by : Dubai PR Network Editorial Team
Viewed 3178 times
PR Category : Healthcare & Medicine
Posted on : Sunday, November 15, 2020  3:52:00 PM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of DubaiPRNetwork.com.
Previous Story : WCU: Vaccine Hopes and Virus Fears Battle for Supremacy
Next Story : 5 Tips for Diabetes Management
Email this article Print this article

Share this article with your friends and followers
NewsVine
Back to Section Home

Related Stories



 
 
Most Viewed Press Release posted in the last 7 days
Devika Bulchandani Named CEO of Ogilvy North America & Global Chairwoman of Advertising [4658-Views]
What You Don't See [3022-Views]
Registrations Now Open for the 3rd Edition of the Dubai Festival City Santa Run [2718-Views]
National Geographic Premieres Virus Hunters: A Chilling Chronicle of the Heroic Experts on... [2657-Views]
Persil Rewards Aspiring Abaya Designers With Scholarships [2554-Views]
Al Tayer Motors Wins Ford Trucks' Champions Award 2019 [2546-Views]
Discover Your Perfect Shade of Beige this Autumn/ Winter from Emilia-Romagna [2517-Views]
MBRU-LED Genetic Study Reveals Crucial Insights Into Make-up of MRSA Superbug [2394-Views]
"Be Flawless" for the Perfect Complexion [2157-Views]
Celebrate the True Beauty of Emirati Scents this National Day with LOOTAH Perfumes [2128-Views]
Karl Lagerfeld Introduces a New Style in the Fall-Winter 2020 Eyewear Collection [2107-Views]
UAE Businesses Urged to Follow WHO Legionella Guidelines To Avoid Health Risks [2058-Views]
DHA Approves Saliva for COVID-19 Testing in Children [2034-Views]
Invesco Analysis Shows Investors Using Futures for Gold Exposure May Be Overpaying [1968-Views]
IATA Travel Pass Key to Reopening Borders Safely [1960-Views]
Samsung Invites UAE Consumers to Experience the All New Air Dresser at Galeries Lafayette [1947-Views]
Philips World COPD Day Survey Reveals Global Shifts in Awareness and Action Surrounding Re... [1927-Views]
Sanctuary Refined: New Lincoln Nautilus Brings Serene Design, Elevated Technology to Midsi... [1911-Views]
AquaChemie Breaks Ground on $40 M Petrochemical Terminal at Jebel Ali Port [1816-Views]
Now Open: Union Coop's Al Warqa City Mall is here [1808-Views]
SLC discusses role of government policies in achieving stable and quality legislation duri... [1771-Views]
Dubai Health Authority Launches a New Stand-alone Laboratory Facility [1742-Views]
Last Chance to avail Carrefour Friday's Unparalleled Discounts Across UAE [1734-Views]
Genesis Luxury Flagship SUV the GV80 Debuts in the Middle East & Africa [1726-Views]
Millions of Lung Cancer Patients See Gene Therapy and Immunotherapy Medical Innovations as... [1706-Views]
 
RSS Facebook Twitter LinkedDin
 
Top Sections
 
Top Stories